Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model

EUROPEAN JOURNAL OF PHARMACOLOGY · Published 2026-07-28 · DOI 10.1016/j.ejphar.2026.179186

Authors (10)

Qianqian Zhao, Min Zheng, Xiaobo Wan, Bingjie Li, Xi Yang, Caixia Gao, Zhiming Han, Huabing Sun, Yuan Fu, Xiangjian Zheng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhao, Q., Zheng, M., Wan, X., et al. (2026). Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model. EUROPEAN JOURNAL OF PHARMACOLOGY. https://doi.org/10.1016/j.ejphar.2026.179186

Related articles